| Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer F Graziano, N Galluccio, P Lorenzini, A Ruzzo, E Canestrari, S D'Emidio, ... Journal of clinical oncology 29 (36), 4789-4795, 2011 | 210 | 2011 |
| HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response A Palladini, G Nicoletti, A Lamolinara, M Dall’Ora, T Balboni, ML Ianzano, ... Oncotarget 8 (33), 54444, 2017 | 26 | 2017 |
| The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival? E Franceschi, A Mura, D De Biase, G Tallini, A Pession, MP Foschini, ... Future Oncology 14 (16), 1559-1567, 2018 | 23 | 2018 |
| Prognostic impact of HER-2 Subclonal Amplification in breast cancer E Di Oto, AA Brandes, MC Cucchi, MP Foschini Virchows Archiv 471, 313-319, 2017 | 23 | 2017 |
| X chromosome gain in male breast cancer E Di Oto, V Monti, MC Cucchi, R Masetti, Z Varga, MP Foschini Human pathology 46 (12), 1908-1912, 2015 | 23 | 2015 |
| HER2 Amplification Status in Feline Mammary Carcinoma: A Tissue Microarray–Fluorescence In Situ Hydridization–Based Study LV Muscatello, E Di Oto, G Sarli, V Monti, MP Foschini, C Benazzi, ... Veterinary pathology 56 (2), 230-238, 2019 | 22 | 2019 |
| Transplanted human adipose tissue-derived stem cells engraft and induce regeneration in mice olfactory neuroepithelium in response to dichlobenil subministration V Franceschini, S Bettini, S Pifferi, A Menini, G Siciliano, E Ognio, AT Brini, ... Chemical Senses 39 (7), 617-629, 2014 | 22 | 2014 |
| Increased expression of pro-angiogenic factors and vascularization in thyroid hyperfunctioning adenomas with and without TSH receptor activating mutations M Celano, M Sponziello, G Tallini, V Maggisano, R Bruno, M Dima, ... Endocrine 43, 147-153, 2013 | 20 | 2013 |
| Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion G Marucci, E Di Oto, A Farnedi, R Panzacchi, C Ligorio, MP Foschini Human pathology 43 (3), 374-380, 2012 | 19 | 2012 |
| Pathological spectrum in recurrences of glioblastoma multiforme. G Marucci, PV Fabbri, L Morandi, D De Biase, E Di Oto, G Tallini, ... Pathologica 107 (1), 1-8, 2015 | 17 | 2015 |
| X chromosome gain is related to increased androgen receptor expression in male breast cancer E Di Oto, GB Biserni, Z Varga, L Morandi, MC Cucchi, R Masetti, ... Virchows Archiv 473, 155-163, 2018 | 14 | 2018 |
| Next-generation sequencing panel for 1p/19q codeletion and IDH1-IDH2 mutational analysis uncovers mistaken overdiagnoses of 1p/19q codeletion by FISH D de Biase, G Acquaviva, M Visani, G Marucci, A De Leo, T Maloberti, ... The Journal of Molecular Diagnostics 23 (9), 1185-1194, 2021 | 13 | 2021 |
| Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft L Landuzzi, A Palladini, C Ceccarelli, S Asioli, G Nicoletti, V Giusti, ... Scientific reports 11 (1), 1563, 2021 | 12 | 2021 |
| HER2 overexpression and cytogenetical patterns in canine mammary carcinomas LV Muscatello, F Gobbo, E Di Oto, G Sarli, R De Maria, A De Leo, G Tallini, ... Veterinary Sciences 9 (11), 583, 2022 | 10 | 2022 |
| Preferential expression of NY-BR-1 and GATA-3 in male breast cancer GB Biserni, E Di Oto, LE Moskovszky, MP Foschini, Z Varga Journal of cancer research and clinical oncology 144, 199-204, 2018 | 8 | 2018 |
| Simultaneous occurrence of PAX8-PPARg and RET-PTC3 rearrangements in a follicular variant of papillary thyroid carcinoma P Caria, T Dettori, DV Frau, E Di Oto, L Morandi, A Parmeggiani, G Tallini, ... The American Journal of Surgical Pathology 36 (9), 1415-1420, 2012 | 8 | 2012 |
| Postsurgical Approaches in Low‐Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option? E Franceschi, A Tosoni, D De Biase, G Lamberti, D Danieli, S Pizzolitto, ... The Oncologist 24 (5), 664-670, 2019 | 5 | 2019 |
| Chromosome X aneusomy and androgen receptor gene copy number aberrations in apocrine carcinoma of the breast A Cremonini, L Saragoni, L Morandi, AG Corradini, C Ravaioli, E Di Oto, ... Virchows Archiv 479 (2), 345-354, 2021 | 4 | 2021 |
| Genetic markers of oral malignant melanoma analysed by fluorescence in situ hybridisation (FISH) C Baldovini, AL Tosi, E Di Oto, C Reggiani, S Cappia, CM Betts, C Gallo, ... Virchows Archiv 459, 167-173, 2011 | 4 | 2011 |
| Low grade glioma patients with IDH mutation and 1p19q codeletion: To treat or not to treat? E Franceschi, D De Biase, A Paccapelo, A Mura, A Tosoni, S Bartolini, ... Journal of Clinical Oncology 35 (15_suppl), 2017-2017, 2017 | 1 | 2017 |
